Hyperoxia inhibits several critical aspects of vascular development

Developmental Dynamics

Volumn 236, Issue 4, 2007, Pages 981-990

  Uno, Koichi ^a   Merges, Carol A ^a   Grebe, Rhonda ^a   Lutty, Gerard A ^a   Prow, Tarl W ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Angioblasts; Angiogenesis; CXCR4; Endothelial cells; Hyperoxia; Retina; Vasculogenesis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; LOW DENSITY LIPOPROTEIN; PLATELET DERIVED GROWTH FACTOR; SMOOTH MUSCLE ACTIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BLAST CELL; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; DOG; ENDOTHELIUM CELL; HYPEROXIA; LIPID TRANSPORT; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; RETROLENTAL FIBROPLASIA;

ANIMALS; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOSKELETON; DOGS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; OXYGEN; OXYGEN CONSUMPTION; RETINAL VESSELS;

EID: 34247395052     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21122     Document Type: Article

References (35)

1. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. 1995. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1:1024-1028.
2. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. 1997. Biological roles of fibroblast growth factor-2. Endocr Rev 18:26-45.
3. Chan-Ling T, McLeod DS, Hughes S, Baxter L, Chu Y, Hasegawa T, Lutty GA. 2004. Astrocyte-endothelial cell relationships during human retinal vascular development. Invest Ophthalmol Vis Sci 45: 2020-2032
4. D'Amore PA, Sweet E. 1987. Effects of hyperoxia on microvascular cells in vitro. In Vitro Cell Dev Biol 23:123-128.
5. Gong J, Traganos F, Darzynkiewicz Z. 1994. Staurosporine blocks cell progression through G1 between the cyclin D and cyclin E restriction points. Cancer Res 54:3136-3139.
6. Gu X, Samuel S, El-Shabrawey M, Caldwell RB, Bartoli M, Marcus DM, Brooks SE. 2002. Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci 43:496-502.
7. Gu X, El-Remessy AB, Brooks SE, Al-Shabrawey M, Tsai NT, Caldwell RB. 2003. Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite. Am J Physiol Cell Physiol 285:C546-C554.
8. Helt CE, Rancourt RC, Staversky RJ, O'Reilly MA. 2001. p53-dependent induction of p21(Cip1/WAF1/Sdi1) protects against oxygen-induced toxicity. Toxicol Sci 63:214-222.
9. Hughes S, Yang H, Chan-Ling T. 2000. Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Invest Ophthalmol Vis Sci 41: 1217-1228.
10. International Committee for the Classification of Retinopathy of Prematurity. 2005. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 123:991-999.
11. Kermorvant-Duchemin E, Sennlaub F, Sirinyan M, Brault S, Andelfinger G, Kooli A, Germain S, Ong H, d'Orleans-Juste P, Gobeil F Jr, Zhu T, Boisvert C, Hardy P, Jain K, Falck JR, Balazy M, Chemtob S. 2005. Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration. Nat Med 11:1339-1345.
12. Ko JC, Wang YT, Yang JL. 2004. Dual and opposing roles of ERK in regulating G(1) and S-G(2)/M delays in A549 cells caused by hyperoxia. Exp Cell Res 297:472-483.
13. Lutty GA, Mathews MK, Merges C, McLeod DS. 1998. Adenosine stimulates canine retinal microvascular endothelial cell migration and tube formation. Curr Eye Res 17:594-607.
14. Lutty GA, Merges C, McLeod DS. 2000. 5′ nucleotidase and adenosine during retinal vasculogenesis and oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 41:218-229.
15. Lutty GA, Merges C, Grebe R, Prow T, McLeod DS. 2006. Canine retinal angioblasts are multipotent. Exp Eye Res 83: 183-193
16. Maltepe E, Simon MC. 1998. Oxygen, genes, and development: an analysis of the role of hypoxic gene regulation during murine vascular development. J Mol Med 76:391-401.
17. McLeod DS, Lutty GA, Wajer SD, Flower RW. 1987. Visualization of a developing vasculature. Microvasc Res 33:257-269.
18. McLeod DS, Brownstein R, Lutty GA. 1996. Vaso-obliteration in the canine model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 37:300-311.
19. McLeod DS, D'Anna SA, Lutty GA. 1998. Clinical and histopathologic features of canine oxygen-induced proliferative retinopathy. Invest Ophthalmol Vis Sci 39: 1918-1932.
20. McLeod DS, Hasegawa T, Prow T, Merges C, Lutty G. 2006. The initial fetal human retinal vasculature develops by vasculogenesis. Dev Dyn 235:3336-3347.
21. Neu J, Afzal A, Pan H, Gallego E, Li N, Li Calzi S, Caballero S, Spoerri PE, Shaw LC, Grant MB. 2006. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 47:3151-3155.
22. O'Reilly MA. 2001. DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking to facilitate repair. Am J Physiol Lung Cell Mol Physiol 281:L291-L305.
23. Patz A. 1984. Current concepts of the effect of oxygen on the developing retina. Curr Eye Res 3:159-163.
24. Penn JS, Thum LA, Naash MI. 1992. Oxygen-induced retinopathy in the rat. Vitamins C and E as potential therapies. Invest Ophthalmol Vis Sci 33:1836-1845.
25. Poole TJ, Finkelstein EB, Cox CM. 2001. The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev Dyn 220:1-17.
26. Recchia FM, Capone A Jr. 2004. Contemporary understanding and management of retinopathy of prematurity. Retina 24: 283-292.
27. Salvucci O, Yao L, Villalba S, Sajewicz A, Pittaluga S, Tosato G. 2002. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 99:2703-2711.
28. Saugstad OD. 2005. Oxygen for newborns: how much is too much? J Perinatol 25(Suppl 2):S45-S49; discussion S50.
29. Schleef RR, Birdwell CR. 1982. The effect of fibrin on endothelial cell migration in vitro. Tissue Cell 14:629-636.
30. Schulenburg WE, Tsanaktsidis G. 2004. Variations in the morphology of retinopathy of prematurity in extremely low birthweight infants. Br J Ophthalmol 88: 1500-1503.
31. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA. 1994. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101-111.
32. Subhani M, Combs A, Weber P, Gerontis C, DeCristofaro JD. 2001. Screening guidelines for retinopathy of prematurity: the need for revision in extremely low birth weight infants. Pediatrics 107:656-659.
33. Vanderveen DK, Mansfield TA, Eichenwald EC. 2006. Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity. J AAPOS 10: 445-448.
34. Voyta JC, Via DP, Butterfield CE, Zetter BR. 1984. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 99:2034-2040.
35. Wilkinson-Berka JL, Babic S, De Gooyer T, Stitt AW, Jaworski K, Ong LG, Kelly DJ, Gilbert RE. 2004. Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy. Am J Pathol 164:1263-1273.